I

Intellia Therapeutics, Inc.

460 employees

Intellia Therapeutics is a genome editing company that develops curative gene-editing treatments.

Investor insights

Sectors invested in

Biotechnology2
Life Science2
Health Care1
Therapeutics1
cell therapy1
lupus1
autoimmune1

Funding rounds participated in

$85M sweet spot round size

Most of their 2 investments are in rounds between $85M and $85M

Basic info

Industry

biotechnology

Sectors

Biotechnology
Health Care
Therapeutics
Genetics
Medical

Date founded

2014

Investments made

K

Kyverna Therapeutics raised $85M on January 26, 2022

Investors: LYFE Capital, Hudson Bay Capital Management LP, Westlake Village BioPartners®, Insight Partners, Vida Ventures, LLC, RTW Investments, LP, Northpond Ventures and Intellia Therapeutics, Inc.

S

SparingVision raised undisclosed on October 13, 2021

Investors: Intellia Therapeutics, Inc.

Funding rounds raised

Total raised

$70M

from 6 investors over 6 rounds

I

Intellia Therapeutics, Inc. raised $70M on September 1, 2015

Investors: Sectoral Asset Management, Foresite Capital, OrbiMed Advisors and Atlas Venture

I

Intellia Therapeutics, Inc. raised $15M on November 18, 2014

Investors: Caribou Biosciences and Atlas Venture

FAQ